PACKAGE LEAFLET: Information for the user. amlodipino cinfa 5 mg tablets

Similar documents
AMLODIPINE 5 MG TABLETS AMLODIPINE 10 MG TABLETS Amlodipine

Package leaflet: Information for the user. Amlodipin Aurobindo 10 mg tablets. Amlodipine

PATIENT INFORMATION LEAFLET

Amlodipin Bluefish 10 mg tablets. amlodipine

Package leaflet: Information for the user. Amlodipin Accord 10 mg tablets. Amlodipine

Amlodipine Pfizer 5 mg and 10 mg tablets Amlodipine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 10 mg Tablets. (Amlodipine Besilate)

NL/H/882/ / Amlodipine CT 5 mg, tabletten Amlodipine CT 10 mg, tabletten

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 5 mg Tablets Amlodipine 10 mg Tablets (Amlodipine Besilate)

Package leaflet: Information for the user

PACKAGE LEAFLET Page 1 of 6

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine maleate. Read all of this leaflet carefully before you start taking this medicine.

NL/H/880/01-02 FINAL PL

Package leaflet: Information for the patient

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

Blooms The Chemist Amlodipine / Atorvastatin

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

Package leaflet: Information for the patient. Co-amoxiclav 250 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

AMLODIPINE GENERICHEALTH

Amoxicillin 250mg Hard Capsules Amoxicillin 500mg Hard Capsules

Package leaflet: information for the user

Keep this leaflet with your medicine. You may want to read it again. What this medicine is used for

1. WHAT CO-AMOXICLAV TABLETS IS AND WHAT IT IS USED FOR

New Zealand Consumer Medicine Information

Package leaflet: Information for the user

Package leaflet: Information for the patient. Desloratadine Cipla 5 mg film-coated tablets. Desloratadine

2 What you need to know before you take Augmentin

BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER. Deslorasam 5 mg filmomhulde tabletten Desloratadine

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg film-coated tablets. amoxicillin/ clavulanic acid

PATIENT INFORMATION LEAFLET GENTAMICIN 10MG/ML SOLUTION FOR INJECTION OR INFUSION. and GENTAMICIN 40MG/ML SOLUTION FOR INJECTION OR INFUSION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Moxifloxacin tablets (as moxifloxacin hydrochloride)

PACKAGE LEAFLET Page 1 of 7

2. What you need to know before you take Doxycycline capsule

Package leaflet: Information for the patient Genticin 80mg/2ml Solution for Injection Gentamicin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Amoxicilline/Clavulaanzuur Torrent 500 mg/125 mg filmomhulde tabletten. Amoxicillin Clavulanic acid

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

Package leaflet: Information for the user. Desloratadine Archie Samuel 5 mg filmomhulde tabletten Desloratadine

OFLOXACIN TABLETS MEDICATION GUIDE

Package leaflet: Information for the user Augmentin 875 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

MEDICATION GUIDE FLOXIN [Flox in] (ofloxacin)

For a copy of a large print leaflet, Ph: Read this leaflet carefully before taking your medicine.

ANNEX III AMENDMENTS TO THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER. GENTAMICIN VISION 3 mg/g eye ointment Gentamicin

Moxifloxacin APOTEX Contains the active ingredient moxifloxacin (as hydrochloride monohydrate)

Package leaflet: Information for the user

Package leaflet: Information for the user. Moxifloxacin 400 mg film-coated tablets. Adults Active substance: Moxifloxacin

Package leaflet: Information for the patient. Flomocin 400mg film-coated tablets Moxifloxacin

DEPO-MEDROL methylprednisolone acetate

Package leaflet: Information for the patient. Germentin 500 mg/125 mg film coated tablets Amoxicillin/clavulanic acid

DBL Doxycycline Doxycycline Hydrochloride (dox-i-sye-kleen)

FDA-Approved Medication Guide MEDICATION GUIDE Moxifloxacin Hydrochloride Tablets (mox'' i flox' a sin hye'' droe klor' ide) Rx only

Minims Chloramphenicol

PACKAGE LEAFLET: INFORMATION FOR THE USER

uk-pl-nl0979v026-clean.doc Page 1 of 9

NL/H/880/01-02 FINAL SMPC

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (HYDROmorphone Hydrochloride) Sterile Solution for Injection

ENALAPRIL HCT 20mg/12.5mg tablets

B. PACKAGE LEAFLET 1

B. PACKAGE LEAFLET 1

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION HYDROmorphone Hydrochloride Injection USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION N HYDROmorphone HP 10

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Antibiotics. Information for patients and carers Pharmacy Department. Patient information leaflet

SUMMARY OF PRODUCT CHARACTERISTICS

Enalapril maleate /Hydrochlorothiazide (20 mg/ 12.5 mg tablets) NL/H/0377/001/R/ proposed track version package leaflet Page 1 of 9

Package leaflet: Information for the user. AUGMENTIN DUO 400 mg/57 mg/5 ml powder for oral suspension Amoxicillin/clavulanic acid

One Amlodipine KRKA 5 mg or 10 mg tablet contains amlodipine maleate equivalent to either 5 mg or 10 mg amlodipine per tablet.

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

[09/2018] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

B. PACKAGE LEAFLET 1

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. HYDROCORTISON CUM CHLORAMPHENICOL 5 mg/g + 2 mg/g eye ointment hydrocortisone acetate, chloramphenicol

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

Veterinary Medicinal Product

SUMMARY OF PRODUCT CHARACTERISTICS

A first-line treatment for ear infections in children with ear tubes*

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Simplicef is Used to Treat Animals with Skin Infections

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

SUMMARY OF PRODUCT CHARACTERISTICS. Pharmasin 250 mg/g Premix for medicated feeding stuff for pigs, broilers and pullets

Transcription:

PACKAGE LEAFLET: Information for the user amlodipino cinfa 5 mg tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What amlodipino cinfa is and what it is used for 2. What you need to know before you take amlodipino cinfa 3. How to take amlodipino cinfa 4. Possible side effects 5. How to store amlodipino cinfa 6. Contents of the pack and other information 1. What amlodipino cinfa is and what it is used for amlodipino cinfa contains the active substance amlodipino, which belongs to a group of drugs known as calcium antagonists. amlodipino cinfa is used to treat high blood pressure (hypertension) or a certain type of chest pain called angina, a rare form of which is Prinzmetal s or variant angina. In patients with high blood pressure this medicine works by relaxing the blood vessels so that blood passes through them more easily. In patients with angina, amlodipino cinfa works by improving the blood supply to the heart muscle, which thus receives more oxygen and as a result chest pain is prevented. This medicine does not provide immediate relief of chest pain due to angina. 2. What you need to know before you take amlodipino cinfa Do not take amlodipino cinfa If you are allergic (hypersensitive) to amlodipino or any of the other ingredients of this medicine (see section 6), or to any other calcium antagonists. This may be itching, reddening of the skin or difficulty breathing. If you have severe low blood pressure (hypotension). If you have narrowing of the aortic heart valve (aortic stenosis) or cardiogenic shock (an illness where your heart is unable to pump enough blood to the body). If you suffer from heart failure after a heart attack. Warnings and precautions Talk to your doctor or pharmacist before taking amlodipino cinfa. You should inform your doctor if you have or have had any of the following conditions: Recent heart attack

Heart failure Severe increase in blood pressure (hypertensive crisis) Liver disease You are elderly and your dose needs to be increased Children and adolescents amlodipino cinfa has not been studied in children under the age of 6 years. amlodipino cinfa should only be used to treat hypertension in children and adolescents from 6 to 17 years of age (see section 3). For more information, talk to your doctor. Other medicines and amlodipino cinfa: Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. amlodipino cinfa may affect or be affected by other medicines, such as: ketoconazole, itraconazole (anti-fungal medicines) ritonavir, indinavir, nelfinavir (also called protease inhibitors, used to treat AIDS) rifampicin, erythromycin, clarithromycin (antibiotics) Hypericum perforatum (St. John s Wort) verapamil, diltiazem (heart medicines) dantrolene (infusion for severe body temperature abnormalities) tacrolimus (medicine used to modify the immune system) simvastatin (medicine that lowers cholesterol) ciclosporin (an immunosuppressant) If you are already taking other medicines to treat your high blood pressure, amlodipino cinfa may lower your blood pressure even more. amlodipino cinfa with food and drink Grapefruit juice and grapefruit should not be consumed by people who are taking amlodipino cinfa. This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active ingredient amlodipino, which can cause an unpredictable increase in the blood pressure lowering effect of amlodipino cinfa. Pregnancy The safety of amlodipino during pregnancy has not been established. If you think you might be pregnant, or are planning to get pregnant, you must tell your doctor before you take amlodipino cinfa. Breast-feeding Amlodipino has been shown to pass into breast milk in small amounts. If you are breast-feeding, or about to start breast-feeding, you must tell your doctor before taking amlodipino cinfa. Ask your doctor or pharmacist for advice before using any medicine. Driving and using machines amlodipino cinfa may affect your ability to drive or use machines. If the tablets make you feel sick, dizzy or tired, or give you a headache, do not drive or use machines and contact your doctor immediately.

3. How to take amlodipino cinfa Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The recommended initial dose is 5 mg of amlodipino cinfa once a day. The dose can be increased to 10 mg of amlodipino cinfa once a day. This medicine can be taken before or after meals. You should take it at the same time each day with a glass of water. Do not take amlodipino cinfa with grapefruit juice. Use in children and adolescents For children and adolescents (6-17 years old), the normally recommended initial dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day. Amlodipino 2.5 mg is not currently available and the 2.5 mg dose cannot be obtained with amlodipino cinfa 5 mg tablets, as these tablets are not manufactured to be divided into equal halves. It is important to keep taking the tablets. Do not wait until your tablets are finished to see your doctor. If you take more amlodipino cinfa than you should Taking too many tablets may cause your blood pressure to become low or even dangerously low. You may feel dizzy, dazed, faint when you get up or weak. If the drop in blood pressure is severe enough, shock can occur. Your skin could feel cool and clammy and you could lose consciousness. If you take too many amlodipino cinfa tablets, seek immediate medical attention or call the Toxicological Information Service, tel. +34 91 562 04 20. If you forget to take amlodipino cinfa Do not worry. If you forget to take a tablet, do not take that dose. Take your next dose at the right time. Do not take a double dose to make up for a forgotten dose. If you stop taking amlodipino cinfa Your doctor will tell you how long to take this medicine. Your condition may recur if you stop using this medicine before your doctor tells you. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, amlodipino cinfa can cause side effects, although not everybody gets them. Visit your doctor immediately if you experience any of the following very rare severe side effects after taking this medicine. Sudden wheezing, chest pain, shortness of breath or difficulty breathing Swelling of the eyelids, face or lips Swelling of the tongue and throat, which causes great difficulty breathing Severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and inflammation of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome, toxic epidermal necrolysis) or other allergic reactions Heart attack, abnormal heart beat Inflammation of the pancreas, which may cause severe abdominal and back pain accompanied by feeling very unwell.

The following very common side effect has been reported. If this causes you problems or if it lasts for more than one week, contact your doctor. Very common: may affect more than 1 in 10 patients Oedema (fluid retention). The following common side effects have been reported. If any of these cause you problems or if they last for more than one week, contact your doctor. Common: may affect up to 1 in 10 patients Headache, dizziness, drowsiness (especially at the beginning of treatment) Palpitations (awareness of your heart beat), flushing Abdominal pain, feeling sick (nausea) Altered bowel habits, diarrhoea, constipation, indigestion Tiredness, weakness Visual disturbances, double vision Muscle cramps Ankle swelling Other side effects that have been reported are included in the following list. If you feel that any side effect that you suffer is serious, or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist. Uncommon: may affect up to 1 in 100 patients Mood changes, anxiety, depression, insomnia Tremor, taste abnormalities, fainting Numbness or tingling sensation in the limbs, loss of pain sensation Ringing in the ears Low blood pressure Sneezing/runny nose caused by inflammation of the lining of the nose (rhinitis), cough Dry mouth, vomiting (being sick) Hair loss, increased sweating, itchy skin, red patches on the skin, skin discolouration Problems passing urine, increased need to urinate at night, increased number of times passing urine Inability to obtain an erection, discomfort or enlargement of the breasts in men Pain, feeling unwell Joint or muscle pain, back pain Weight gain or loss Rare: may affect up to 1 in 1000 patients Confusion Very rare: may affect up to 1 in 10,000 patients Decrease in the number of white blood cells, decrease in blood platelets, which may result in easy bleeding or unusual bruising Excess sugar in the blood (hyperglycaemia) A disorder of the nerves that can cause muscle weakness, tingling or numbness Inflamed gums Abdominal bloating (gastritis) Abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), increase in liver enzymes, which may have an effect on some medical tests Increased muscle tension Inflammation of the blood vessels, often with skin rash Sensitivity to light Disorders combining rigidity, tremor and/or movement disorders

Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Medicines for Human Use: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store amlodipino cinfa Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the container after EXP. The expiry date refers to the last day of that month. Do not store above 25ºC. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What amlodipino cinfa contains: - The active substance is amlodipino. Each tablet contains 5 mg of amlodipino. - The other ingredients are: microcrystalline cellulose, calcium hydrogen phosphate, sodium carboxymethyl potato starch (potato starch) and magnesium stearate. What amlodipino cinfa looks like and contents of the pack: amlodipino cinfa is supplied as white scored tablets in PVC/Aluminium blisters in packs of 30 tablets. Marketing authorisation holder and manufacturer: Laboratorios Cinfa, S.A. C/ Olaz-Chipi, 10 - Polígono Industrial Areta 31620 Huarte-Pamplona (Navarre) Spain. or Pabianickie Zakłady Farmaceutyczne Polfa S.A. ul. Marszałka J. Piłsudskiego 5 95-200 Pabianice Poland This leaflet was last revised in: January 2018 Detailed and updated information on this medicine can be found on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/.

PACKAGE LEAFLET: Information for the user amlodipino cinfa 10 mg tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What amlodipino cinfa is and what it is used for 2. What you need to know before you take amlodipino cinfa 3. How to take amlodipino cinfa 4. Possible side effects 5. How to store amlodipino cinfa 6. Contents of the pack and other information 1. What amlodipino cinfa is and what it is used for amlodipino cinfa contains the active substance amlodipino, which belongs to a group of drugs known as calcium antagonists. amlodipino cinfa is used to treat high blood pressure (hypertension) or a certain type of chest pain called angina, a rare form of which is Prinzmetal s or variant angina. In patients with high blood pressure this medicine works by relaxing the blood vessels so that blood passes through them more easily. In patients with angina, amlodipino cinfa works by improving the blood supply to the heart muscle, which thus receives more oxygen and as a result chest pain is prevented. This medicine does not provide immediate relief of chest pain due to angina. 2. What you need to know before you take amlodipino cinfa Do not take amlodipino cinfa If you are allergic (hypersensitive) to amlodipino or any of the other ingredients of this medicine (see section 6), or to any other calcium antagonists. This may be itching, reddening of the skin or difficulty breathing. If you have severe low blood pressure (hypotension). If you have narrowing of the aortic heart valve (aortic stenosis) or cardiogenic shock (an illness where your heart is unable to pump enough blood to the body). If you suffer from heart failure after a heart attack. Warnings and precautions Talk to your doctor or pharmacist before taking amlodipino cinfa. You should inform your doctor if you have or have had any of the following conditions: Recent heart attack

Heart failure Severe increase in blood pressure (hypertensive crisis) Liver disease You are elderly and your dose needs to be increased Children and adolescents amlodipino cinfa has not been studied in children under the age of 6 years. amlodipino cinfa should only be used to treat hypertension in children and adolescents from 6 to 17 years of age (see section 3). For more information, talk to your doctor. Other medicines and amlodipino cinfa: Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. amlodipino cinfa may affect or be affected by other medicines, such as: ketoconazole, itraconazole (anti-fungal medicines) ritonavir, indinavir, nelfinavir (also called protease inhibitors, used to treat AIDS) rifampicin, erythromycin, clarithromycin (antibiotics) Hypericum perforatum (St. John s Wort) verapamil, diltiazem (heart medicines) dantrolene (infusion for severe body temperature abnormalities) tacrolimus (medicine used to modify the immune system) simvastatin (medicine that lowers cholesterol) ciclosporin (an immunosuppressant) If you are already taking other medicines to treat your high blood pressure, amlodipino cinfa may lower your blood pressure even more. amlodipino cinfa with food and drink Grapefruit juice and grapefruit should not be consumed by people who are taking amlodipino cinfa. This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active ingredient amlodipino, which can cause an unpredictable increase in the blood pressure lowering effect of amlodipino cinfa. Pregnancy The safety of amlodipino during pregnancy has not been established. If you think you might be pregnant, or are planning to get pregnant, you must tell your doctor before you take amlodipino cinfa. Breast-feeding Amlodipino has been shown to pass into breast milk in small amounts. If you are breast-feeding, or about to start breast-feeding, you must tell your doctor before taking amlodipino cinfa. Ask your doctor or pharmacist for advice before using any medicine. Driving and using machines amlodipino cinfa may affect your ability to drive or use machines. If the tablets make you feel sick, dizzy or tired, or give you a headache, do not drive or use machines and contact your doctor immediately.

3. How to take amlodipino cinfa Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The recommended initial dose is 5 mg of amlodipino cinfa once a day. The dose can be increased to 10 mg of amlodipino cinfa once a day. This medicine can be taken before or after meals. You should take it at the same time each day with a glass of water. Do not take amlodipino cinfa with grapefruit juice. Use in children and adolescents For children and adolescents (6-17 years old), the normally recommended initial dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day. Amlodipino 2.5 mg is not currently available and the 2.5 mg dose cannot be obtained with amlodipino cinfa 5 mg tablets, as these tablets are not manufactured to be divided into equal halves. It is important to keep taking the tablets. Do not wait until your tablets are finished to see your doctor. If you take more amlodipino cinfa than you should Taking too many tablets may cause your blood pressure to become low or even dangerously low. You may feel dizzy, dazed, faint when you get up or weak. If the drop in blood pressure is severe enough, shock can occur. Your skin could feel cool and clammy and you could lose consciousness. If you take too many amlodipino cinfa tablets, seek immediate medical attention or call the Toxicological Information Service, tel. +34 91 562 04 20. If you forget to take amlodipino cinfa Do not worry. If you forget to take a tablet, do not take that dose. Take your next dose at the right time. Do not take a double dose to make up for a forgotten dose. If you stop taking amlodipino cinfa Your doctor will tell you how long to take this medicine. Your condition may recur if you stop using this medicine before your doctor tells you. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, amlodipino cinfa can cause side effects, although not everybody gets them. Visit your doctor immediately if you experience any of the following very rare severe side effects after taking this medicine. Sudden wheezing, chest pain, shortness of breath or difficulty breathing Swelling of the eyelids, face or lips Swelling of the tongue and throat, which causes great difficulty breathing Severe skin reactions including intense skin rash, hives, reddening of the skin over your whole body, severe itching, blistering, peeling and inflammation of the skin, inflammation of mucous membranes (Stevens Johnson Syndrome, toxic epidermal necrolysis) or other allergic reactions Heart attack, abnormal heart beat Inflammation of the pancreas, which may cause severe abdominal and back pain accompanied by feeling very unwell.

The following very common side effect has been reported. If this causes you problems or if it lasts for more than one week, contact your doctor. Very common: may affect more than 1 in 10 patients Oedema (fluid retention). The following common side effects have been reported. If any of these cause you problems or if they last for more than one week, contact your doctor. Common: may affect up to 1 in 10 patients Headache, dizziness, drowsiness (especially at the beginning of treatment) Palpitations (awareness of your heart beat), flushing Abdominal pain, feeling sick (nausea) Altered bowel habits, diarrhoea, constipation, indigestion Tiredness, weakness Visual disturbances, double vision Muscle cramps Ankle swelling Other side effects that have been reported are included in the following list. If you feel that any side effect that you suffer is serious, or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist. Uncommon: may affect up to 1 in 100 patients Mood changes, anxiety, depression, insomnia Tremor, taste abnormalities, fainting Numbness or tingling sensation in the limbs, loss of pain sensation Ringing in the ears Low blood pressure Sneezing/runny nose caused by inflammation of the lining of the nose (rhinitis), cough Dry mouth, vomiting (being sick) Hair loss, increased sweating, itchy skin, red patches on the skin, skin discolouration Problems passing urine, increased need to urinate at night, increased number of times passing urine Inability to obtain an erection, discomfort or enlargement of the breasts in men Pain, feeling unwell Joint or muscle pain, back pain Weight gain or loss Rare: may affect up to 1 in 1000 patients Confusion Very rare: may affect up to 1 in 10,000 patients Decrease in the number of white blood cells, decrease in blood platelets, which may result in easy bleeding or unusual bruising Excess sugar in the blood (hyperglycaemia) A disorder of the nerves that can cause muscle weakness, tingling or numbness Inflamed gums Abdominal bloating (gastritis) Abnormal liver function, inflammation of the liver (hepatitis), yellowing of the skin (jaundice), increase in liver enzymes, which may have an effect on some medical tests Increased muscle tension Inflammation of the blood vessels, often with skin rash Sensitivity to light Disorders combining rigidity, tremor and/or movement disorders

Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Medicines for Human Use: http://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store amlodipino cinfa Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the container after EXP. The expiry date refers to the last day of that month. Do not store above 25ºC. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What amlodipino cinfa contains: - The active substance is amlodipino. Each tablet contains 10 mg of amlodipino. - The other ingredients are: microcrystalline cellulose, calcium hydrogen phosphate, sodium carboxymethyl potato starch (potato starch) and magnesium stearate. What amlodipino cinfa looks like and contents of the pack: amlodipino cinfa is supplied as white scored tablets in PVC/Aluminium blisters in packs of 30 tablets. Marketing authorisation holder and manufacturer: Laboratorios Cinfa, S.A. C/ Olaz-Chipi, 10 - Polígono Industrial Areta 31620 Huarte-Pamplona (Navarre) Spain. or Pabianickie Zakłady Farmaceutyczne Polfa S.A. ul. Marszałka J. Piłsudskiego 5 95-200 Pabianice Poland This leaflet was last revised in: January 2018 Detailed and updated information on this medicine can be found on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/.